IV iron

DRUG9 trials

Conditions

Anaemia in Ovarian CarcinomaAnemiaAnemia, Iron DeficiencyCardiovascular Disease (CVD)Chronic Kidney DiseaseChronic Kidney Disease (CKD)DialysisEnd Stage Renal Disease

Phase 2

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

CompletedNCT01414075

Kyntra BioAnemia, Dialysis

Start: 2011-07-21End: 2013-01-10Updated: 2021-10-01

Phase 3

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

CompletedNCT02504294

PfizerChronic Kidney Disease (CKD)

Start: 2015-07-13End: 2016-07-16Updated: 2018-06-13

HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?

CompletedNCT02631980

University Hospital, GenevaAnemia, Postoperative Blood Loss

Start: 2015-10-31End: 2016-10-31Updated: 2017-05-05

Effect of Intravenously Iron Infusion on the Prevention and Treatment of Anemia in Ovarian Cancer

Not yet recruitingNCT06248749

University of SaskatchewanAnaemia in Ovarian Carcinoma

Start: 2024-02-29End: 2029-12-01Target: 200Updated: 2024-02-08

Phase 4

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

TerminatedNCT00830037

Indiana UniversityChronic Kidney Disease, Iron-deficiency Anemia

Start: 2008-08-31Updated: 2016-07-21

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

WithdrawnNCT03286205

Sutter Gould Medical FoundationAnemia, Iron Deficiency

Start: 2015-04-14End: 2018-08-31Updated: 2019-06-05

Postpartum IV Iron to Treat Iron Deficiency Anemia Post Delivery Trial

Active, not recruitingPACTR202307876581314

National Institute of Child Health and DevelopmentHaematological Disorders

Start: 2023-08-01Target: 600Updated: 2026-01-27

Unknown Phase

The Effect of Pomegranate Juice (PJ) on Oxidative Stress Biomarkers During Treatment With IV Iron During One Dialysis Session

CompletedNCT02107053

Western Galilee Hospital-NahariyaCardiovascular Disease (CVD)

Start: 2014-04-30End: 2016-01-31Updated: 2016-02-09

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial

TerminatedNCT03214627

Vifor Fresenius Medical Care Renal PharmaAnemia, End Stage Renal Disease

Start: 2018-12-10End: 2019-05-21Updated: 2020-01-07

Related Papers

Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (Retacrit<sup>TM</sup>) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis

American Journal of Nephrology2018-01-018 citations

Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial.

2013-03-2028 citations